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Aim: For patients with superficial esophageal carcinoma, ESD was one of treatment modalities to remove the lesion
safely and effectively. We perform this meta-analysis to determine the efficacy and incidence of complication of
ESD for patients with superficial esophageal carcinoma.
Method: Articles were searched in MEDLINE (PubMed and Ovid), Cochrane Database of Systemic Reviews, Google
scholar, and Web of Science. Two reviewers independently searched and extracted data. Meta-analysis of the
efficacy of ESD was analyzed by calculating pooled en bloc and R0 resection rate. Incidence of complications such
as perforation, stenosis and mediastinal emphysema was also calculated. Pooling was conducted using either
fixed-effects model or random-effects model depending on the heterogeneity across studies.
Results: 21 studies (1152 patients and 1240 lesions) were included in this analysis. The pooled en bloc resection
rate was 99% (95% CI 99%-100%). Stratified by tumor size, en bloc resection rates did not show any significant
difference. The pooled R0 resection rate was 90% (95% CI 87%-93%). The pooled R0 resection rate was 85% (95% CI,
80%-90%) for large tumor and 92% (95% CI, 87%-93%) for small tumor (p < 0.001). Stenosis served as the most
common reported complication with pooled incidence of 5% (95% CI 3-8%), followed by perforation (1%, 95% CI
0-1%) and mediastinal emphysema (0% CI 0-1%). The incidence of postoperative stenosis decreased significantly
after 2011 (2%, 95% CI 0-3%) compared with that before 2011 (9%, 95% CI 3-8%) (p < 0.001).
Conclusion: ESD was an efficient modality for treating superficial esophageal carcinoma, with perfect en bloc and
R0 resection rate and low complication rate. The most common complication of ESD was stenosis. Although
recurrence rate was low, patients should be maintained in a scheduled surveillance program.
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Introduction
An increasing number of esophageal carcinoma is diag-
nosed worldwide each year [1]. With the improving of
diagnostic technology, esophageal cancer can be diag-
nosed in early stage. Endoscopic treatment of early
esophageal carcinoma has been increasingly conducted
around the world, which aims to maintain the integrity
of the esophagus and avoid the considerable morbidity
and mortality of esophagectomy. Endoscopic mucosal
resection (EMR) was the first developed endoscopic* Correspondence: hujian_med@163.com
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unless otherwise stated.resection strategy. However, EMR is sometimes associ-
ated with local recurrence, especially when lesions larger
than 20 mm are resected in a piecemeal manner [2]. To
overcome the limitation of EMR, endoscopic submuco-
sal dissection (ESD) was developed about 10 years ago
[3]. ESD allows en bloc resection regardless of the size
and precise histological assessment of the specimens
[4,5]. The best result of ESD is that tumors are excised
in one piece with tumor-free lateral basal margins (R0
resection), therefore preventing residual disease and
local margins.
Recently, a number of studies were conducted to as-
sess the efficacy and durability of ESD. However, the re-
sults of these studies were rather controversial with the
R0 resection rate ranging from 71% to 97% [6,7].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of the standard treatments for superficial esophageal
carcinoma (SEC) in Japan [8], it is highly technique
demanding because the wall of the esophagus is thinner
than that of stomach and the narrow lumen of the
esophagus restricts endoscopic manipulation. As a re-
sult, life-threatening complications such as perforation
and mediastinal emphysema occur with the incidence of
4-10% [8-10].
We perform this meta-analysis to: (1) analysis the en
bloc and R0 resection rate of ESD for SEC; (2) analysis
the local recurrence rate after ESD; (3) analysis the inci-
dence of complications of ESD to treat SEC.
Methods
Search strategy
This study was conducted following the Meta-analysis
Of Observational Studies in Epidemiology guidelines
[11]. Electronic literature searches were conducted from
1 January 1980 to 1 December 2013. MEDLINE (PubMed
and Ovid), Cochrane Database of Systemic Reviews, Goo-
gle scholar, and Web of Science were searched for eligible
studies. A systemic literature search was performed with
the search term “(ESD OR endoscopic submucosal dissec-
tion) AND esophag*”. References of all relevant articles
were also scanned for potential missing studies. Articles
with full text in English were retrieved. The retrieved stud-
ies were carefully examined to avoid potential duplicates
or overlapping data. No attempt was made to locate un-
published material or contact researchers for unpublished
data.
Study selection and review process
To be eligible, studies had to meet the following criteria:
(1) esophageal cancer was histologically proven; (2) ESD
(not EMR) was conducted; (3) En bloc or R0 resection
rate was reported (4) no age or gender restrictions; (5)
published in a peer-reviewed journal from 1 January
1980 to 1 December 2013.
We excluded: (1) non-English language studies; (2)
nonhuman studies; (3) reviews and case reports; (4)
studies with mean follow up periods less than 6 months;
(5) studies with less than 20 patients; (6) study samples
that are duplicatly reported.
Data collection and quality assessment
Data were collected independently by two investigators
(Fenghao Sun and Ping Yuan) from each study using a
predefined data table, with disagreements being resolved
by consensus. For each study, the following characteris-
tics were collected: first author’s name, year of publica-
tion, number of patients, the country in which the study
was carried out, study design, faculty, kinds of knife and
hooks that was used, ESD and surveillance protocol,en bloc and R0 resection rate, time of procedure, occur-
rence and types of complications, histopathologic types
of biopsies and follow up evaluation time. Recorded
patient characteristics included age and gender. The
quality of each study was assessed using the previously
validated Downs and Black [12] instrument, which can
assess both randomized and nonrandomized studies.
After abstraction, the authors reviewed the evidence ta-
bles and discrepancies again were resolved by consensus.
Efficacy outcomes and complications
The primary efficacy outcomes were en bloc resection,
defined as the complete removal of the tumor including
the markings into one nonfragmented piece, and R0
resection, defined as complete tumor removal with both
lateral and deep margins free of neoplastic cells.
Efficacy outcomes were tabulated according to lesion
size (The maximum diameter of the lesion was consid-
ered to be the lesion size). The primary durability out-
come was local recurrence rate of neoplasm defined
histologically after R0 resection. Complications (most
commonly perforation, stenosis, mediastinal emphysema
and bleeding) were recorded as secondary outcomes.
These were ascertained based on the individual study
definitions of adverse events. Generally, perforation was
diagnosed during ESD. Mediastinal emphysema was di-
agnosed by the presence of air in the mediastinal space
on a chest radiograph or CT scan. Bleeding was defined
when patients required blood transfusion during proced-
ure, or a postoperative bleeding that required hemostatic
treatment such as endoscopic clipping and coagulation.
Stenosis was defined as a stricture that required endo-
scopic treatment.
Statistical analysis
Statistical analysis was performed using Stata version
12.1 (Stata Corp LP, College Station, TX). En bloc and
R0 resection rates were pooled by either fixed-effects
model or random-effects model depending on the het-
erogeneity across studies. A random-effect model was
applied if heterogeneity was significant; otherwise, a
fixed-effects model was adopted. I2 and Cochran’s Q
tests were performed to assess the heterogeneity across
studies (for the Cochran Q test, heterogeneity was
present if P < 0.05, while values of I2 to 25, 50, and 75%
represented low, moderate, and high heterogeneity, re-
spectively) [13]. To identify potential sources of hetero-
geneity, analyses were repeated for each subset of the
studies. Additional stratified analysis were performed by
sample size (D ≥ 25 mm vs D < 25 mm, 25 mm is the
mean diameter of all the lesions of included studies) and
year of publication (before 2011 vs after 2011). Although
ESD has been improving all the time, there was no turn-
ing point where a revolutionary improvement took place.
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improved in this decade compared with last decade. All
p values presented were two-sided. The association was
considered significant if the p value was less than 0.05.
Results
Search results
After initial search, 729 articles were identified (Figure 1).
Among these, 643 were excluded after the first screening
based on abstracts and titles. An additional 65 records
were excluded after abstract and full-text review for
reasons such as non-English language (n = 2), irrelevant
report (n = 14), reviews (n = 8), fewer than 20 subjects
(n = 6), mean follow up less than 6 month (n = 2), duplicate
reports of study samples (n = 1), meeting abstract (n = 2),
no data of either en bloc or R0 resection rate (n = 13), SEC
originating from the muscularis propria layer (n = 2),
Sampling bias (n = 4), combined data (n = 3), animal re-
port (n = 2), case reports and letters (n = 6). Therefore, 21
studies with 1152 patients (1240 lesions) which met the
inclusion criteria were included [2,4-10,14-29].Figure 1 Study flow diagram.Study characteristics
Included studies were published between 2005 and 2013.
All but three studies were performed in Japan. The other
3 studies were performed in China, Brazil and Italy, re-
spectively. There were two studies lacking en bloc resec-
tion rate and one study R0 resection rate. Substantial
variability exists in terms of number of patients and
instruments. The majority of studies used insulation-
tipped knife (IT knife), hook knife, needle knife, or the
combination of these knives. Number of patients ranged
from 20 to 138. The number of lesions that exceeded
3/4 of esophageal circumference was available only in 6
studies. As for histopathology, 12 studies included squa-
mous cell carcinoma, 8 included adenocarcinoma, and 5
included high-grade dysplasia. Mean follow up period
ranged from 12 to 53 months. Four studies did not
declare a specific follow-up period but noted to be at
least 12 months. Mean ages of patients were around
70 with only one exception. 5 studies did not specify
age information. The majority of included patients
were male. The characteristics for all included studies
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full-text articles.
Efficacy outcomes
The pooled en bloc resection rate was 99% (95% CI 99%-
100%). Stratified by tumor size, en bloc resection rates
did not show any difference. The polled en bloc resec-
tion rate was 99% (95% CI, 98%-100%) for large tumor
(D ≥ 25 mm) and 100% (95% CI, 99%-100%) for small
tumor (Figure 2).
The pooled R0 resection rate was 90% (95% CI 87%-
93%). The pooled R0 resection rate was 85% (95% CI,
80%-90%) for large tumor and 92% (95% CI, 87%-93%)
for small tumor (p < 0.001) (Figure 3).
Complications and recurrence
Stenosis served as the most common reported complica-
tion with pooled incidence of 5% (95% CI 3-8%) (Figure 4),
followed by perforation (1%, 95% CI 0-1%) (Figure 5) and
mediastinal emphysema (0%, 95% CI 0-1%) (Figure 6).
Tumor size did not show influence on incidence of perfor-
ation and stenosis. The incidence of postoperative stenosis
decreased significantly after 2011 (2%, 95% CI 0-3%) com-
pared with that before 2011 (9%, 95% CI 3-8%) (p < 0.001)
(Figure 7). However, this trend was not found in the inci-
dence of perforation (Figure 8). The pooled incidence of
mediastinal emphysema was 0% (95% CI 0-1%) (Figure 6).
Since mediastinal emphysema occurred only in 20 pa-
tients distributed in 6 studies, subgroup analysis would be
unnecessary.
Our data showed that only 5 out of 1159 patients de-
veloped histopathologically identified local recurrence. 3
of them were managed by an additional ESD and 1 of
them underwent EMR and 2 sessions of radiofrequency
ablation (RFA) and the other one was not declared.
Heterogeneity
Significant heterogeneity was only found in R0 resection
rate (I2 = 54.6%, p < 0.001) and incidence of stenosis (I2 =
76.0%, p < 0.001).
Discussion
ESD has been recognized as a reliable treatment for
early gastric neoplasms and has been gradually accepted
as a preferred method for the endoscopic treatment of
SEC [30]. However, the use of ESD for SEC is not well
guided. Patients and physician need to be well informed
with the risks and benefits of the procedure. In this sys-
tematic review and meta-analysis, 1152 patients (1240
lesions) of 21 studies were included. The pooled en bloc
(99%, 95% CI 99-100%) and R0 (90%, 95% CI 87-93%)
resection rates were calculated. We also evaluated the
incidence of complication such as perforation (1%, 95%
CI 0-1%), stenosis (5%, 95% CI 3-8%) and mediastinalemphysema (0%, 95% CI 0-1%). Local recurrence only
occurred in 5 patients. Subgroup analysis was also con-
ducted by tumor size and year of publication. For en bloc
resection rate, no significant difference was detected be-
tween large (D ≥ 25 mm) and small tumor (D < 25 mm).
For R0 resection rate, large tumor (85%, 95% CI 80-90%)
had a lower R0 resection rate compared with small
tumor (92%, 95% CI 89-95%). Most studies reported the
en bloc resection rate of over 95% except for two. One
study reported by Repici et al. had an en bloc resection
rate of 90%, probably because of the extremely large
tumor size (mean = 33 mm) [9]. The other one con-
ducted by Arants et al. reported an en bloc resection rate
of 92% which might be resulted from its submucosal
tunnel dissection procedure instead of circumferential
mucosal incision [14]. All but one study achieved R0 re-
section rate of more than 80%.
ESD for esophageal cancer had been proven to be su-
perior to conventional EMR in terms of the R0 resection
rate and the recurrence rate [31]. With ESD, en bloc re-
section can be achieved regardless of the size of the
tumor [4]. It was also proved in our study that en bloc
resection rate did not drop in large tumors. However, R0
resection rate was influenced by the tumor size. Larger
tumors were less likely to achieve R0 resection. The rea-
son for such a phenomenon was understandable that re-
section of larger tumor was more technique-demanding.
In this perspective, though ESD can achieve R0 resection
in large tumors, the R0 resection rate drops.
The risk of complication is unavoidable since ESD
is an endoscopic surgical procedure. Perforation was
considered the most common complication during ESD
procedures [31]. But our data demonstrated that the per-
foration rate was only 1% (95% CI, 0-1%), while the inci-
dence of postoperative stenosis was 5% (95% CI, 3-8%),
making stenosis the major complication for ESD. A
similar result was reported by Sgourakis et al. that the
perforation and stenosis rate were 1.8% and 12.2% re-
spectively [32]. Perforation was considered as the most
severe complications during ESD procedure. Although it
can be temporarily clipped by hemoclips, unstable vital
signs during the procedure might result in an urgent
operation [3,30]. Sgourakis G et al. reported that esopha-
geal stenosis was statistically more prevalent among
patients managed with ESD than EMR [32]. As for
mediastinal emphysema, the occurrence of the complica-
tion was rare according to the studies included.
Interestingly, significant difference of stenosis occur-
rence was found before and after the year of 2011, with
a trend toward reduced occurrence of stenosis after
2011 (p < 0.001). It was reported that a mucosal defect
involving more than three-fourths of the esophageal
circumference was significantly associated with the de-
velopment of severe esophageal stricture after EMR [33].
Table 1 Characteristics of included studies
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Arantes. V 2013 Brazil 23 25 68 25 3 (12%) Flush Knife 0/1/2 21 2 20
Higuchi. K 2013 Japan 52 52 68 20 ND IT knife/Hook-knife/Needle knife 5/0/0 >12 0 22
Fujinami. H 2013 Japan 35 38 68 31.9 ND Stag beetle/Hook knife 0/1/8 >12 1 20
Sohara. N 2013 Japan 59 64 68 23 ND NR 0/1/0 24 0 22
Imai. K 2013 Japan 49 50 72 ND ND IT knife 3/0/0 47 0 23
Omae. M 2013 Japan 44 44 70 17 ND IT knife 0/0/0 33 0 18
Toyonaga. T 2013 Japan 138 138 69 23 ND IT knife/Hook-knife/Needle knife 0/0/0 53 0 19
Lee. C T 2012 China 20 24 48 33.7 2 (8.3%) IT knife 3/1/1 12 0 22
Yamashita. T 2011 Japan 71 71 NR 30 11 (15.4%) IT knife/needle knife 6/1/0 39 0 21
Urabe. Y 2011 Japan 59 79 65 ND ND IT knife/Hook knife 4/6/0 36 0 22
Nonaka. K 2010 Japan 25 27 NR 21 ND Hook knife/Flash knife/flex knife 3/1/0 >12 0 22
Hirasawa. K 2010 Japan 58 58 69 37.7 ND IT knife/Needle knife 1/0/0 30 0 21
Takahashi. H 2010 Japan 116 116 67 30 26 (22%) Hook knife/Needle-knife 20/3/0 36 0 23
Repici. A 2010 Italy 20 20 64 32 ND IT knife/Hook knife 1/0/2 36 0 20
Ishii. N 2010 Japan 35 37 67 22 ND Hook knife/Flex knife 9/0/0 19 0 20
Ono. S 2009 Japan 84 107 NR 22.9 10 (9.3%) Flex knife/Splash needle 15/4/1 21 1 22
Fujishiro. M 2009 Japan 79 102 NR 22 9 (8.8%) Flex-knife/Splash-needle 13/4/0 25 1 16
Ishihara. R 2008 Japan 29 31 64 16 ND Hook-knife 3/1/0 >12 0 21
Yoshinaga. S 2008 Japan 24 25 62 16.5 ND IT knife 2/0/0 31 0 21
Kakushima. N 2006 Japan 30 30 70 22.5 ND Flex knife 0/1/0 15 0 20















Figure 2 Forest plots of en bloc rate of ESD, stratified by tumor size (D ≥ 25 mm vs. D < 25 mm).
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and histologic depth of lesion can be reliable independ-
ent predictors for postoperative stenosis [34]. However,
with only 6 studies specified the number of lesions that
exceeded 3/4 of esophageal circumference, it is hard toFigure 3 Forest plots of R0 resection rate of ESD, stratified by tumorevaluate the relationship in this study. Instead, we fur-
ther confirmed in our study that tumor size did not
show influence on incidence of perforation and stenosis.
The possibility exists that a more rigorous selection of
indications may contribute to the decreasing stenosissize (D ≥ 25 mm vs. D < 25 mm).
Figure 4 Forest plots of the proportion of patients developed stenosis after ESD, stratified by tumor size (D ≥ 25 mm vs. D < 25 mm).
Figure 5 Forest plots of perforation rate during ESD, stratified by tumor size (D ≥ 25 mm vs. D < 25 mm).
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Figure 6 Forest plots of the proportion of patients developed mediastinal emphysema after ESD.
Figure 7 Forest plots of the proportion of patients developed stenosis after ESD, stratified by year of publication (after 2011 vs.
before 2011).
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Figure 8 Forest plots of perforation rate during ESD, stratified by year of publication (after 2011 vs. before 2011).
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occupied >3/4 esophageal circumference may not suit-
able for ESD during recent years. Nevertheless, improve-
ments of surgical techniques and devices during last few
years should not be ignored. It is demonstrated in Table 1
that the insulation-tipped knife was more widely used in
combination of devices after 2011. Before that, hook
knife and flex knife were the mainstay devices used in
each center. Fujinami et al. reported that the use of the
stag beetle (SB) knife for esophageal ESD reduced the
risk of complications [16]. Moreover, efficient interven-
tion decreased the incidence and severity of stenosis
after endoscopic resection involving more than 75% cir-
cumference when preventative dilatation was carried out
[31]. Among these interventions, the scheduled endo-
scopic balloon dilatation (EBD) after ESD and local injec-
tion of steroids were the most applied methods. EBD has
been a choice in the setting of benign esophageal stric-
tures [35-37]. Local steroid injection into corrosive or
anastomotic strictures could achieve remission of dyspha-
gia, with 26.5% to 56% less incidence compared to control
groups without intralesional steroid injection [38-40].
It is considered that, compared with EMR, ESD
showed a better en bloc and R0 resection rate for the
treatment of superficial esophageal tumors, leading to a
reduced local recurrence rate [31]. Our data of local re-
currence showed a similar result that only 5 out of 1159
patients developed histopathologically identified localrecurrence. This finding suggested that the possibility of
local recurrence should not be overlooked even after R0
resection. Thus, we suggest patients should be main-
tained in a scheduled surveillance program.
Although stratification by tumor size showed higher
R0 resection rate for small tumor (D < 25 mm), hetero-
geneity was not fully explained. Also, heterogeneity of in-
cidence of stenosis was significant across included studies.
It was not surprising owing to the difference in patient
samples, settings and protocols, instruments and provider
factors. As for stenosis, different center may use different
modalities to prevent the occurrence of stenosis, which
may explain the significant heterogeneity.
There were also several limitations in this study. First,
since most of the included studies were conducted in
Japan, it can hardly represent the basic characteristics of
patients worldwide. Further efforts should be focused on
conducting clinical trials in western centers for further
research. Second, heterogeneity was not fully explained.
Heterogeneity of R0 resection rate for small tumor and
incidence of stenosis were significant. Third, follow-up
duration was not long enough which may lead to the
underestimation of recurrence rate.
Conclusions
In summary, this systematic review and meta-analysis
showed that (1) ESD was an efficient modality for treat-
ing SEC, with perfect en bloc and R0 resection rate and
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http://www.cardiothoracicsurgery.org/content/9/1/78low complication rate; (2) Compared with large tumor
(D ≥ 25 mm), ESD for small tumor (D < 25 mm) had a
higher R0 resection rate; (3) The incidence of stenosis
dropped recently compared with several years ago.
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